Alessandra Tosolini

Alessandra Tosolini has a diverse and extensive work experience in the field of clinical research and oncology. Alessandra is currently working as the Vice President at Stemline Therapeutics since October 2022. Prior to this, they held the position of Senior Director, Oncology Clinical Development; Clinical Research Lead for BLENREP at GSK from May 2019 to October 2022.

From March 2017 to May 2019, Alessandra was the Director, Program Lead CRS at Celgene. Before that, they worked as a Senior Clinical Research Scientist at Celgene from January 2015 to March 2017. Alessandra's earlier experience includes working as an Associate Director/Associate Principal Scientist - Clinical Research Oncology at Merck from September 2009 to January 2015.

Before joining Merck, Alessandra was a Staff Biologist at Merck & Co., Department of Genetic and Cellular Toxic from May 2004 to September 2009. Alessandra also worked as a Clinical Data Reviewer at Clinforce Inc. from January 2004 to May 2004 and as a Data Reviewer at Kelly Scientific Resources from May 2003 to August 2003.

Their career in research began as a Research Assistant at Fox Chase Cancer Center from February 1998 to January 2001. Alessandra also served as a Research Specialist at the University of Pennsylvania from 2001 to 2003. Overall, Alessandra has gained significant expertise and leadership skills throughout their various roles in the pharmaceutical industry.

Alessandra Tosolini has a Bachelor's Degree in Biology, General from Drexel University, which they completed in the year 2002. Prior to that, they obtained another Bachelor's Degree in Biomedical and Biotechnological Sciences from Sapienza Università di Roma, which they completed from 1993 to 1996.